[Insulin-induced lipoatrophy--caused by monocomponent insulin?].
Authors give case history of two patients for type II diabetes treated with insulin by whom with monocomponent insulin lipoatrophy developed on the region of insulin administration. In the case of one of them the problem was solved by elimination of technical fault, the local reaction of other patient ceased only by converting to human insulin into the lipoatrophic region. In the latter case dynamics of contemporaneous psoriatic change raises immunological connections.
Gyimesi
A
A
Iványi
J
J
D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects*; D007332:Insulin Infusion Systems / Q000009:adverse effects; D008060:Lipodystrophy / Q000139:chemically induced* / Q000188:drug therapy; D008875:Middle Aged
D007328:Insulin
Inzulin-indukálta lipoatrophia--MC inzulintól?